ketanserin has been researched along with Delayed Effects, Prenatal Exposure in 3 studies
Ketanserin: A selective serotonin receptor antagonist with weak adrenergic receptor blocking properties. The drug is effective in lowering blood pressure in essential hypertension. It also inhibits platelet aggregation. It is well tolerated and is particularly effective in older patients.
ketanserin : A member of the class of quinazolines that is quinazoline-2,4(1H,3H)-dione which is substituted at position 3 by a 2-[4-(p-fluorobenzoyl)piperidin-1-yl]ethyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with ketanserine resulted in an antidepressant-like effect in prenatally stressed OVX females in the FST as compared to the control group." | 5.42 | [Pecularities for action of combined administration of NAN-190 and ketanserine with low dose of 17β-estradiol on depression-like behavior in prenatally stressed ovariectomized rats]. ( Akulova, VK; Fedotova, IuO; Ordian, NÉ; Pivina, SG, 2015) |
| "Control and maternally separated litters received treatment with the 5-HT(2) receptor antagonist, ketanserin, or vehicle during postnatal life and were examined for effects on adult anxiety behavior, adult stress-induced immediate early gene expression responses, and transcriptional changes within the prefrontal cortex during postnatal life and in adulthood." | 3.77 | Postnatal serotonin type 2 receptor blockade prevents the emergence of anxiety behavior, dysregulated stress-induced immediate early gene responses, and specific transcriptional changes that arise following early life stress. ( Benekareddy, M; Nair, AR; Vadodaria, KC; Vaidya, VA, 2011) |
| "Treatment with ketanserine resulted in an antidepressant-like effect in prenatally stressed OVX females in the FST as compared to the control group." | 1.42 | [Pecularities for action of combined administration of NAN-190 and ketanserine with low dose of 17β-estradiol on depression-like behavior in prenatally stressed ovariectomized rats]. ( Akulova, VK; Fedotova, IuO; Ordian, NÉ; Pivina, SG, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fedotova, IuO | 1 |
| Pivina, SG | 1 |
| Akulova, VK | 1 |
| Ordian, NÉ | 1 |
| Benekareddy, M | 1 |
| Vadodaria, KC | 1 |
| Nair, AR | 1 |
| Vaidya, VA | 1 |
| McOmish, CE | 1 |
| Gingrich, JA | 1 |
3 other studies available for ketanserin and Delayed Effects, Prenatal Exposure
| Article | Year |
|---|---|
[Pecularities for action of combined administration of NAN-190 and ketanserine with low dose of 17β-estradiol on depression-like behavior in prenatally stressed ovariectomized rats].
Topics: Animals; Behavior, Animal; Depression; Drug Administration Schedule; Drug Therapy, Combination; Estr | 2015 |
Postnatal serotonin type 2 receptor blockade prevents the emergence of anxiety behavior, dysregulated stress-induced immediate early gene responses, and specific transcriptional changes that arise following early life stress.
Topics: Age Factors; Analysis of Variance; Animals; Animals, Newborn; Anxiety; Apoptosis Regulatory Proteins | 2011 |
Stress and the baby brain.
Topics: Animals; Anxiety; Female; Gene Expression Regulation; Ketanserin; Male; Pregnancy; Prenatal Exposure | 2011 |